Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Autoimmune Disease Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Autoimmune Disease Treatmentmarket, defines the market attractiveness level of Autoimmune Disease Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Autoimmune Disease Treatment industry, describes the types of Autoimmune Disease Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Autoimmune Disease Treatment market and the development prospects and opportunities of Autoimmune Disease Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Autoimmune Disease Treatment market in Chapter 13.
By Player:
AstraZeneca plc
Pfizer
Lupin Limited
4SC AG
Bayer
F Hoffmann-La Roche Ltd
GlaxoSmithKline
Eli Lilly
Amgen
Abbott Laboratories
AutoImmune Inc
Biogen Idec
Active Biotech
Bristol-Myers Squibb
Johnson & Johnson
By Type:
Immunosuppressant’s
Anti-inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs
Biologics
By End-User:
Hospitals
Clinics
Drug Stores
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Autoimmune Disease Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Autoimmune Disease Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Autoimmune Disease Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Autoimmune Disease Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Autoimmune Disease Treatment Market Analysis and Outlook to 2022
-
7.1 Global Autoimmune Disease Treatment Consumption (2017-2022)
-
7.2 United States Autoimmune Disease Treatment Consumption (2017-2022)
-
7.3 Europe Autoimmune Disease Treatment Consumption (2017-2022)
-
7.4 China Autoimmune Disease Treatment Consumption (2017-2022)
-
7.5 Japan Autoimmune Disease Treatment Consumption (2017-2022)
-
7.6 India Autoimmune Disease Treatment Consumption (2017-2022)
-
7.7 South Korea Autoimmune Disease Treatment Consumption (2017-2022)
8 Region and Country-wise Autoimmune Disease Treatment Market Analysis and Outlook to 2028
-
8.1 Global Autoimmune Disease Treatment Consumption Forecast (2022-2028)
-
8.2 United States Autoimmune Disease Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Autoimmune Disease Treatment Consumption Forecast (2022-2028)
-
8.4 China Autoimmune Disease Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Autoimmune Disease Treatment Consumption Forecast (2022-2028)
-
8.6 India Autoimmune Disease Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Autoimmune Disease Treatment Consumption Forecast (2022-2028)
9 Global Autoimmune Disease Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Autoimmune Disease Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Immunosuppressant’s Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anti-inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Nonsteroidal Anti-inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Biologics Consumption and Growth Rate (2017-2022)
-
9.2 Global Autoimmune Disease Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drug Stores Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Autoimmune Disease Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Autoimmune Disease Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Immunosuppressant’s Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Anti-inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Nonsteroidal Anti-inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Biologics Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Autoimmune Disease Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Autoimmune Disease Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Autoimmune Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Autoimmune Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Autoimmune Disease Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Autoimmune Disease Treatment Market Competitive Analysis
-
14.1 AstraZeneca plc
-
14.1.1 AstraZeneca plc Company Details
-
14.1.2 AstraZeneca plc Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca plc Autoimmune Disease Treatment Product and Service
-
14.2 Pfizer
-
14.2.1 Pfizer Company Details
-
14.2.2 Pfizer Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pfizer Autoimmune Disease Treatment Product and Service
-
14.3 Lupin Limited
-
14.3.1 Lupin Limited Company Details
-
14.3.2 Lupin Limited Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Lupin Limited Autoimmune Disease Treatment Product and Service
-
14.4 4SC AG
-
14.4.1 4SC AG Company Details
-
14.4.2 4SC AG Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 4SC AG Autoimmune Disease Treatment Product and Service
-
14.5 Bayer
-
14.5.1 Bayer Company Details
-
14.5.2 Bayer Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bayer Autoimmune Disease Treatment Product and Service
-
14.6 F Hoffmann-La Roche Ltd
-
14.6.1 F Hoffmann-La Roche Ltd Company Details
-
14.6.2 F Hoffmann-La Roche Ltd Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 F Hoffmann-La Roche Ltd Autoimmune Disease Treatment Product and Service
-
14.7 GlaxoSmithKline
-
14.7.1 GlaxoSmithKline Company Details
-
14.7.2 GlaxoSmithKline Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GlaxoSmithKline Autoimmune Disease Treatment Product and Service
-
14.8 Eli Lilly
-
14.8.1 Eli Lilly Company Details
-
14.8.2 Eli Lilly Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Eli Lilly Autoimmune Disease Treatment Product and Service
-
14.9 Amgen
-
14.9.1 Amgen Company Details
-
14.9.2 Amgen Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Amgen Autoimmune Disease Treatment Product and Service
-
14.10 Abbott Laboratories
-
14.10.1 Abbott Laboratories Company Details
-
14.10.2 Abbott Laboratories Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Abbott Laboratories Autoimmune Disease Treatment Product and Service
-
14.11 AutoImmune Inc
-
14.11.1 AutoImmune Inc Company Details
-
14.11.2 AutoImmune Inc Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 AutoImmune Inc Autoimmune Disease Treatment Product and Service
-
14.12 Biogen Idec
-
14.12.1 Biogen Idec Company Details
-
14.12.2 Biogen Idec Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Biogen Idec Autoimmune Disease Treatment Product and Service
-
14.13 Active Biotech
-
14.13.1 Active Biotech Company Details
-
14.13.2 Active Biotech Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Active Biotech Autoimmune Disease Treatment Product and Service
-
14.14 Bristol-Myers Squibb
-
14.14.1 Bristol-Myers Squibb Company Details
-
14.14.2 Bristol-Myers Squibb Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Bristol-Myers Squibb Autoimmune Disease Treatment Product and Service
-
14.15 Johnson & Johnson
-
14.15.1 Johnson & Johnson Company Details
-
14.15.2 Johnson & Johnson Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Johnson & Johnson Autoimmune Disease Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Autoimmune Disease Treatment
-
Figure Autoimmune Disease Treatment Picture
-
Table Global Autoimmune Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Autoimmune Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Autoimmune Disease Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Autoimmune Disease Treatment Consumption by Country (2017-2022)
-
Figure United States Autoimmune Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Autoimmune Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Autoimmune Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Autoimmune Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Autoimmune Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Autoimmune Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Autoimmune Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Autoimmune Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Autoimmune Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Autoimmune Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Autoimmune Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Autoimmune Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunosuppressant’s Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Nonsteroidal Anti-inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Biologics Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Immunosuppressant’s Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nonsteroidal Anti-inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biologics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Autoimmune Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Autoimmune Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca plc Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca plc Autoimmune Disease Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Autoimmune Disease Treatment Product and Service
-
Table Lupin Limited (Foundation Year, Company Profile and etc.)
-
Table Lupin Limited Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Limited Autoimmune Disease Treatment Product and Service
-
Table 4SC AG (Foundation Year, Company Profile and etc.)
-
Table 4SC AG Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table 4SC AG Autoimmune Disease Treatment Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Autoimmune Disease Treatment Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Autoimmune Disease Treatment Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Autoimmune Disease Treatment Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Autoimmune Disease Treatment Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Autoimmune Disease Treatment Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Autoimmune Disease Treatment Product and Service
-
Table AutoImmune Inc (Foundation Year, Company Profile and etc.)
-
Table AutoImmune Inc Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AutoImmune Inc Autoimmune Disease Treatment Product and Service
-
Table Biogen Idec (Foundation Year, Company Profile and etc.)
-
Table Biogen Idec Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Autoimmune Disease Treatment Product and Service
-
Table Active Biotech (Foundation Year, Company Profile and etc.)
-
Table Active Biotech Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Active Biotech Autoimmune Disease Treatment Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Autoimmune Disease Treatment Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Autoimmune Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Autoimmune Disease Treatment Product and Service
-
